STAAR Surgical Company (STAA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, STAAR Surgical Company (STAA) has a cash flow conversion efficiency ratio of 0.054x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($19.69 Million) by net assets ($365.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see STAA stock market capitalisation for the company's overall valuation and market capitalisation.
STAAR Surgical Company - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how STAAR Surgical Company's cash flow conversion efficiency has evolved over time, based on yearly financial data.
STAAR Surgical Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STAAR Surgical Company ranked by their cash flow conversion efficiency. Explore STAAR Surgical Company (STAA) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Sunmoon Microelectronics Co. Ltd. A
SHG:688699
|
0.007x |
|
Evergreen Steel Corp
TW:2211
|
0.034x |
|
Medartis Holding AG
SW:MED
|
0.088x |
|
Iradimed Co
NASDAQ:IRMD
|
0.058x |
|
Green Plains Renewable Energy Inc
NASDAQ:GPRE
|
-0.050x |
|
Vitec Software Group AB (publ)
ST:VIT-B
|
0.018x |
|
Bombay Burmah Trading Corporation Limited
NSE:BBTC
|
0.039x |
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
-0.068x |
Annual Cash Flow Conversion Efficiency for STAAR Surgical Company (1990–2025)
The table below shows the annual cash flow conversion efficiency of STAAR Surgical Company from 1990 to 2025. View STAAR Surgical Company (STAA) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $344.18 Million | $-34.23 Million | -0.099x | -351.29% |
| 2024-12-31 | $397.33 Million | $15.72 Million | 0.040x | +4.66% |
| 2023-12-31 | $385.95 Million | $14.59 Million | 0.038x | -64.41% |
| 2022-12-31 | $336.11 Million | $35.72 Million | 0.106x | -37.50% |
| 2021-12-31 | $258.56 Million | $43.96 Million | 0.170x | +60.06% |
| 2020-12-31 | $197.22 Million | $20.95 Million | 0.106x | -34.16% |
| 2019-12-31 | $159.88 Million | $25.80 Million | 0.161x | +67.35% |
| 2018-12-31 | $132.43 Million | $12.77 Million | 0.096x | +45.09% |
| 2017-12-31 | $42.94 Million | $2.85 Million | 0.066x | +140.10% |
| 2016-12-31 | $37.91 Million | $1.05 Million | 0.028x | +149.72% |
| 2015-12-31 | $38.85 Million | $-2.16 Million | -0.056x | +74.03% |
| 2014-12-31 | $37.10 Million | $-7.95 Million | -0.214x | -348.41% |
| 2013-12-31 | $38.85 Million | $3.35 Million | 0.086x | -14.87% |
| 2012-12-31 | $31.74 Million | $3.22 Million | 0.101x | -44.15% |
| 2011-12-31 | $29.46 Million | $5.35 Million | 0.181x | +192.14% |
| 2010-12-31 | $22.43 Million | $-4.42 Million | -0.197x | -390.80% |
| 2009-12-31 | $21.07 Million | $1.43 Million | 0.068x | +113.19% |
| 2008-12-31 | $16.03 Million | $-8.23 Million | -0.513x | -66.29% |
| 2007-12-31 | $36.23 Million | $-11.18 Million | -0.309x | -13.40% |
| 2006-12-31 | $31.76 Million | $-8.65 Million | -0.272x | -57.54% |
| 2005-12-31 | $40.37 Million | $-6.98 Million | -0.173x | +25.68% |
| 2004-12-31 | $37.86 Million | $-8.80 Million | -0.233x | -98.67% |
| 2003-12-31 | $35.42 Million | $-4.15 Million | -0.117x | -730.49% |
| 2002-12-31 | $30.65 Million | $569.00K | 0.019x | +133.98% |
| 2001-12-31 | $46.83 Million | $-2.56 Million | -0.055x | +40.35% |
| 2000-12-31 | $58.67 Million | $-5.37 Million | -0.092x | -199.42% |
| 1999-12-31 | $53.20 Million | $4.90 Million | 0.092x | +4.10% |
| 1998-12-31 | $48.60 Million | $4.30 Million | 0.088x | -47.84% |
| 1997-12-31 | $44.80 Million | $7.60 Million | 0.170x | -26.95% |
| 1996-12-31 | $36.60 Million | $8.50 Million | 0.232x | +33.31% |
| 1995-12-31 | $28.70 Million | $5.00 Million | 0.174x | -4.18% |
| 1994-12-31 | $22.00 Million | $4.00 Million | 0.182x | +318.18% |
| 1993-12-31 | $12.00 Million | $-1.00 Million | -0.083x | +80.38% |
| 1992-12-31 | $7.30 Million | $-3.10 Million | -0.425x | +62.73% |
| 1991-12-31 | $4.30 Million | $-4.90 Million | -1.140x | -13.95% |
| 1990-12-31 | $100.00K | $-100.00K | -1.000x | -- |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorde… Read more